Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: a multi-center, open-label phase 2 study

CONCLUSIONS: Long-term outcomes from the phase 2 SMART trial demonstrate encouraging OS and limited severe toxicity. Additional prospective evaluation of this novel strategy is warranted.PMID:38135187 | DOI:10.1016/j.radonc.2023.110064

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - December 22, 2023 Category: Radiology Authors: Michael D Chuong Percy Lee Daniel A Low Joshua Kim Kathryn E Mittauer Michael F Bassetti Carri K Glide-Hurst Ann C Raldow Yingli Yang Lorraine Portelance Kyle R Padgett Bassem Zaki Rongxiao Zhang Hyun Kim Lauren E Henke Alex T Price Joseph D Mancias Chris Source Type: research